Ling-Min Lu is an accomplished professional in the field of pharmacovigilance, currently serving as the Vice President of Pharmacovigilance at Inventiva Pharma and Simcere Pharmaceutical Group since 2024 and June 2022, respectively. With extensive experience at companies such as Transcenta, Sanofi, and Novartis, Ling-Min has held various key positions including Sr. Vice President of Global Pharmacovigilance and Global Safety Officer. The professional background encompasses safety data evaluation, benefit-risk assessment, and clinical overview drafting, alongside significant research contributions as a Principal Research Investigator and post-doctoral fellow. Educational qualifications include a PhD in pathology, immunology, hematological oncology, and population genetics from Kyoto University, as well as an MD and Master’s degree in Medicine and Pathology from Hebei Medical University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices